Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil before succinylcholine for prevention of postoperative myalgia
IRCT138712241766N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of remifentanil and succinylcholine in Postoperative myalgia (POM) and postoperative pain (2 arms), sponsored by Kurdistan University of Medical Sciences. Started Dec 2008; status: completed.
02
Drugs
remifentanilsuccinylcholine
03
Conditions
Postoperative myalgia (POM)postoperative pain
Beyond the preview
Go deeper on IRCT138712241766N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138712241766N1.